European Journal of Nuclear Medicine
-
Publication Venue For
- Astatine-211 labeled chimeric anti-tenascin antibody: Phase I trial in brain tumor resection cavity patients. 26:1215-1215. 1999
- Biokinetics and dosimetry in patients administered with (111)In-DOTA-Tyr(3)-octreotide: implications for internal radiotherapy with (90)Y-DOTATOC.. 26:877-886. 1999
- Intraoperative probes and imaging probes.. 26:913-935. 1999
- Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin.. 26:348-357. 1999
- Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patients.. 26:110-120. 1999
- ASTATINE-211 LABELED MONOCLONAL-ANTIBODY - A POTENTIAL AGENT FOR RADIOIMMUNOTHERAPY. 14:245-245. 1988
- CONE BEAM SPECT - AN ACQUISITION GEOMETRY TO INCREASE DETECTION EFFICIENCY. 14:226-226. 1988
- A METHOD FOR QUICKER DETECTION OF CYSTIC DUCT PATENCY BY IDA-SCINTIGRAPHY. 9:A6-A6. 1984